advanced search
Torkel Gren
Science & Technology Officer
Recipharm

Is this your profile?

About

Torkel Gren, PhD, is Senior Director, Technology Officer & Strategic Investments, at Recipharm. He holds degrees in Pharmacy and Business Administration, as well a PhD in Pharmaceutics from Uppsala University (Sweden). He has worked in the pharmaceutical industry since 1988 and has held a number of scientist and manager positions in Europe and the US. He was lead formulator and co-inventor of Detrol OD/Detrusitol SR (tolterodine, Pfizer). Dr Gren is Vice Chairman of the Board of the Swedish Pharmaceutical Society and Board Director of SwedenBio.

Contributions

ROUNDTABLE
ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY
Michael Morgen of Lonza Bend, Torkel Gren of Recipharm, and Yogesh Sadhale of Metrics Contract Services, discuss the current trends and innovations influencing oral drug delivery development and what their respective companies can offer to pharma in this space.

More contributions

ROUNDTABLE
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
In this roundtable discussion, Jeremy Drummond, Stephen Rode and Torkel Gren discuss trends with different drug dosage forms for different routes of administration, the rise of patient centricity including the shift from the blockbuster model to more tailored products.
Top